- Home
- HBNC vs CYRX Comparison
HBNC vs CYRX Comparison
Compare HBNC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBNC | CYRX |
|---|---|---|
| Founded | 1873 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 962.4M | 814.9M |
| IPO Year | 1995 | 2008 |
Fundamental Metrics
Financial Performance| Metric | HBNC | CYRX |
|---|---|---|
| Price | $18.88 | $17.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $21.00 | $13.31 |
| AVG Volume (30 Days) | 412.4K | ★ 451.2K |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $5.52 | $8.45 |
| P/E Ratio | $18.84 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.97 | $7.61 |
| 52 Week High | $21.04 | $17.98 |
Technical Indicators
Market Signals| Indicator | HBNC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 32.78 | 60.29 |
| Support Level | $18.09 | $14.55 |
| Resistance Level | $18.88 | N/A |
| Average True Range (ATR) | 0.37 | 0.56 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 2.60 | 76.11 |
Price Performance
Historical ComparisonAbout HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.